Trends in Oncology (TIO)

ISSN (Print): 2717-5278
ISSN (Online): 2810-9147
APC: ¥: 2000 CNY
Databases: ✥CNKI,
Publishing Time: Acceptance 2 Months

Trends in Oncology (TIO) (Print‑ISSN: 2717‑5278, Online‑ISSN: 2810‑9147) is an open‑access, peer‑reviewed journal. It publishes original articles, review articles, editorials, case reports, letters to the editor, perspectives and comments covering all areas of oncology including molecular biology, pathophysiology, cancer prevention, diagnosis and treatment. In addition, special issues focusing on specific oncology disciplines will be organized and defined. Trends in Oncology aims to publish high‑quality academic papers and promote academic exchanges and advances in scientific research within the field of oncology.


Aims & Scope

Trends in Oncology (TIO) (Print‑ISSN: 2717‑5278, Online‑ISSN: 2810‑9147) is an open‑access, peer‑reviewed journal. It publishes original articles, review articles, editorials, case reports, letters to the editor, perspectives and comments covering all areas of oncology including molecular biology, pathophysiology, cancer prevention, diagnosis and treatment. In addition, special issues focusing on specific oncology disciplines will be organized and defined. Trends in Oncology aims to publish high‑quality academic papers and promote academic exchanges and advances in scientific research within the field of oncology.

Aims

  • To provide a peer-reviewed, open access forum for experimental and clinical cancer research.
  • To publish the latest findings in cancer research, including preliminary results, confirmatory studies, and negative results.
  • To support the dissemination of all types of cancer research submissions, including research papers, clinical reports, and review articles.
  • To advance knowledge in oncology treatment discovery, supporting innovation and improved cancer patient outcomes.

Scope

The journal covers a wide range of topics related to experimental and clinical cancer research, including but not limited to:

Experimental and Translational Cancer Research

  • Preclinical studies on cancer biology, tumorigenesis, and molecular mechanisms of cancer
  • Translational research connecting laboratory discoveries to potential clinical applications
  • Drug development, preclinical testing, and mechanism of action studies for cancer therapies
  • Negative results and confirmatory studies contributing to cancer research knowledge


Clinical Cancer Research and Treatment Discovery

  • Clinical research reports on cancer treatment outcomes, efficacy, and safety
  • Preliminary and advanced clinical trial results for novel cancer therapies
  • Studies on diagnostic, prognostic, and predictive biomarkers in oncology
  • Review articles summarizing advances, controversies, and future directions in cancer treatment
Trends in Oncology (TIO) welcomes manuscripts relevant to experimental and clinical cancer research, including research papers, clinical reports, review articles, preliminary results, confirmatory studies, and negative results. All manuscripts undergo rigorous peer review to ensure quality, relevance, and contribution to advancing cancer research and treatment discovery. As an open access journal, OTD aims to make all types of cancer research findings accessible to the global oncology community.